Retention on lifelong antiretroviral therapy (ART) is essential in sustaining treatment success while preventing HIV drug resistance (HIVDR), especially in resource-limited settings (RLS). In an era of rising numbers of patients on ART, mastering patients in care is becoming more strategic for programmatic interventions. Due to lapses and uncertainty with the current WHO sampling approach in Cameroon, we thus aimed to ascertain the national performance of, and determinants in, retention on ART at 12 months.

Billong, S., Fokam, J., Penda, C., Amadou, S., Kob, D., Billong, E., et al. (2016). Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: Results from a nationwide systematic random sampling. BMC INFECTIOUS DISEASES, 16(1), 678 [10.1186/s12879-016-1991-3].

Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: Results from a nationwide systematic random sampling

COLIZZI, VITTORIO;
2016

Abstract

Retention on lifelong antiretroviral therapy (ART) is essential in sustaining treatment success while preventing HIV drug resistance (HIVDR), especially in resource-limited settings (RLS). In an era of rising numbers of patients on ART, mastering patients in care is becoming more strategic for programmatic interventions. Due to lapses and uncertainty with the current WHO sampling approach in Cameroon, we thus aimed to ascertain the national performance of, and determinants in, retention on ART at 12 months.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/04 - Patologia Generale
English
Con Impact Factor ISI
Antiretroviral therapy; Cameroon; HIV drug resistance early warning indicator; Random sampling; Retention in care
Billong, S., Fokam, J., Penda, C., Amadou, S., Kob, D., Billong, E., et al. (2016). Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: Results from a nationwide systematic random sampling. BMC INFECTIOUS DISEASES, 16(1), 678 [10.1186/s12879-016-1991-3].
Billong, S; Fokam, J; Penda, C; Amadou, S; Kob, D; Billong, E; Colizzi, V; Ndjolo, A; Bisseck, A; Elat, J
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/180669
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 8
social impact